What is TVT?
Transcatheter valve therapy (TVT) is a growing new treatment option for patients with valvular heart disease and has become the core of the Structural Heart Summit.
The maturation of transcatheter aortic valve replacement (TAVR) and the rapid adoption of transcatheter mitral and tricuspid therapies have changed the landscape of the treatment of structural heart disease. Now in its 13th year, TVT: Structural Heart Summit has grown to reflect this evolution and expansion.
The modern integration of non-invasive cardiac imaging, surgical therapies, heart failure management, and novel transcatheter approaches makes the treatment of structural heart disease truly multidisciplinary, further emphasizing the importance of continuing education for professionals diagnosing and caring for those with complex valvular heart disease.
Because of this, TVT 2020 is designed to be a valuable learning experience for all members of the heart team from clinical practitioners, healthcare professionals, and academicians to engineers, scientists, and everyone in between.
We welcome anyone interested in treating valvular and structural heart disease—including clinical cardiologists, cardiac imaging specialists (especially those focused on echo and CT), cardiac and vascular surgeons, electrophysiologists, heart failure specialists, nurse practitioners, physician assistants, cath lab technicians, and members of the medical device community—to join us at TVT 2020 this June.
By the end of this course, participants should be able to:
Discuss the evaluation and management of patients with valvular and structural heart disease
Assess the imaging modalities available for diagnosing valvular and structural heart disease
Describe current and future therapeutic options for valvular and structural heart disease
Demonstrate the skills necessary to perform transcatheter valve therapies, left atrial appendage (LAA) closure, and patent foramen ovale (PFO) closure
CME and MOC Accreditation and Evaluation
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians and by the American Board of Internal Medicine to provide Maintenance of Certification (MOC) points.
The Cardiovascular Research Foundation designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™ (subject to change). Physicians should claim only the credit commensurate with the extent of their participation in the activity.